CDIO Stock Analysis: Buy, Sell, or Hold?
CDIO - Cardio Diagnostics Holdings Inc. Common stock
$1.97
0.09 (4.52%)
▲
5d:
-14.19%
30d:
-62.36%
90d:
-42.08%
WAIT
LOW Confidence
Analysis Updated: Mar 27, 2026 12:00 AM ET
Earnings: May 21, 2026
Get Alerted When CDIO Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
⏸️ WAIT FOR STABILIZATION: CDIO is down 14.2% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
⏸️ WAIT FOR STABILIZATION: CDIO is down 14.2% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
In-depth Analysis How we analyze
Valuation Analysis: CDIO is currently trading at $1.97, which is considered oversold relative to its 30-day fair value range of $2.21 to $5.08.
Technical Outlook: Technically, CDIO is showing sideways momentum. Immediate support is located at $1.85, while resistance sits at $3.02. The stock is showing strong short-term momentum, up 4.5% recently.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $60.00 (+2953.4%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, CDIO is showing sideways momentum. Immediate support is located at $1.85, while resistance sits at $3.02. The stock is showing strong short-term momentum, up 4.5% recently.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $60.00 (+2953.4%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
OVERSOLD
Fair Price Range
$2.21 -
$5.08
Company Quality Score
47/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
87.9%
All Signals
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Mixed technical signals (40/100)
- BULLISH: High volume confirmation
- BULLISH: Strong upward momentum (+4.5%)
- BULLISH: Trading 2953.4% below Wall St target ($60.00)
- WARNING: Recommendation downgraded due to -14.2% 5-day decline - wait for stabilization
Fair Price Analysis
30-Day Fair Range
$2.21 -
$5.08
Current vs Fair Value
OVERSOLD
Support & Resistance Levels
Support Level
$1.85
Resistance Level
$3.03
Current Trend
Sideways
Technical data as of
Mar 27, 2026
Fundamental Context
Wall Street Target
$60.00
(+2953.4%)
Revenue Growth (YoY)
-21.2%
Share & Embed Analysis
Last updated: March 30, 2026 8:55 AM ET
Data refreshes hourly during market hours. Next update: 9:55 AM
Data refreshes hourly during market hours. Next update: 9:55 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is CDIO showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
ONC
BeiGene, Ltd. |
STRONG BUY
24 analysts |
$411 | 47 HOLD |
|
INSM
Insmed Inc |
STRONG BUY
19 analysts |
$213 | 61 BUY |
|
ACLX
Arcellx Inc |
STRONG BUY
18 analysts |
$111 | 57 HOLD |
|
RCKT
Rocket Pharmaceuticals I… |
STRONG BUY
18 analysts |
$8 | 49 HOLD |
|
GPCR
Structure Therapeutics I… |
STRONG BUY
14 analysts |
$109 | 51 HOLD |
